Journal of Clinical Endocrinology & Metabolism, Vol 48, 753-759, Copyright © 1979 by Endocrine Society

ARTICLES

Metabolic clearance rates of the subunits of human chorionic gonadotropin in man

RE Wehmann and BC Nisula

Highly purified preparations of the alpha- and beta-subunits of hCG (hCG alpha and hCG beta) were injected iv in normal subjects. After rapid injection, the disappearance of both subunits from serum was nonlinear when plotted on a semilog graph. A two-component exponential curve was fitted for each subject, and the curve parameters were used to estimate the MCR, apparent initial volume of distribution (Vd), and half-times of disappearance of the rapid and slow phase for each subunit. The Vd of hCG beta was indistinguishable from that of hCG alpha (1958 +/- 131 vs. 1729 +/- 99 ml/m2, respectively). The rapid phase half-time for hCG beta was significantly longer than that of hCG alpha (41.2 +/- 1.7 vs. 13.0 +/- 0.9 min; P less than 0.001), and the slow phase half-time of hCG beta was also significantly longer than that of hCG alpha (236 +/- 41 vs. 76 +/- 19 min; P less than 0.01). The estimated MCR of hCG alpha was 49.7 +/- 1.6 ml/min.m2; this value was significantly greater than that of hCG beta (19.0 +/- 0.7 ml/min.m2; P less than 0.001). No significant differences between sexes in parameters determined for the subunits were observed. Continuous infusion of subunits at a rate of 2.7 microgram/min achieved a steady state blood level of hCG beta that was significantly greater than that of hCG alpha (59.1 +/- 7.8 vs. 24.4 +/- 0.7 ng/ml; P less than 0.02) and gave a MCR of hCG alpha that was 3 times greater than the MCR of hCG beta (72.2 +/- 4.9 vs. 21.6 +/- 2.8 ml/min.m2; P less than 0.001). We conclude that the hCG subunits have similar Vds, but since hCG alpha has much shorter half-times of disappearance in both rapid and slow phases, the MCR of hCG alpha is much greater than that of hCG beta.

This article has been cited by other articles:

				U.-H. Stenman, A. Tiitinen, H. Alfthan, and L. Valmu The classification, functions and clinical use of different isoforms of HCG Hum. Reprod. Update, November 1, 2006; 12(6): 769 - 784. [Abstract] [Full Text] [PDF]

				M. Bergendah and J. D. Veldhuis Is there a physiological role for gonadotrophin oligosaccharide heterogeneity in humans?: III. Luteinizing hormone heterogeneity: a medical physiologist's perspective Hum. Reprod., June 1, 2001; 16(6): 1058 - 1064. [Abstract] [Full Text] [PDF]

				J. J. HSU, T. Y. HSU, T'S. T. HSIEH, Y. K. SOONG, F. J. HSIEH, and K. SPENCER Urine Free Beta-hCG and Total Estriol for Down Syndrome Screening During the Second Trimester in an Asian Population Obstet. Gynecol., July 1, 1999; 94(1): 107 - 111. [Abstract] [Full Text] [PDF]

				J. L. Sharpless, J. G. Supko, K. A. Martin, and J. E. Hall Disappearance of Endogenous Luteinizing Hormone Is Prolonged in Postmenopausal Women J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 688 - 694. [Abstract] [Full Text]

				J. Korhonen, H. Alfthan, P. Ylostalo, J. Veldhuis, and U.-H. Stenman Disappearance of human chorionic gonadotropin and its {alpha}- and ß-subunits after term pregnancy Clin. Chem., November 1, 1997; 43(11): 2155 - 2163. [Abstract] [Full Text] [PDF]